Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04154930 · ClinicalTrials.gov registry record · NA
Restylane-L for Correction of Infraorbital Hollows
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 333
- Enrollment target
NCT04154930: Completed NA study, sponsored by Galderma R&D.
NCT04154930 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 333 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04154930, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 333 participants
- Enrollment target
Study Summary
This is a prospective, randomized, evaluator-blinded, no-treatment controlled, parallel group, multi-center US study to evaluate the safety and effectiveness of Restylane-L® for correction of Infraorbital Hollows.
Primary Outcome
Responder rate was defined as the percentage of participants with at least a 1-point improvement from baseline on the Galderma Infraorbital Hollows Scale (GIHS), on both sides of the face, concurrently. GIHS is a validated 4-point scale used to assess Infraorbital Hollows: 0 (none \[hollowness\]), 1 (mild \[hollowness\]), 2 (moderate \[hollowness\]), 3 (severe \[hollowness\]). Higher score means more severe (worse) hollowness in the infraorbital Hollows.
Interventions
- DEVICE Restylane-L®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2022-04-06 |
| Phase | NA |
What the finished NCT04154930 record still lists
NCT04154930 is an interventional study that assigns participants to a tested intervention. The registered 333 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 1 intervention - of which Restylane-L® is the first listed.
NCT04154930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04154930 about?
NCT04154930 is a clinical study titled "Restylane-L for Correction of Infraorbital Hollows". This is a prospective, randomized, evaluator-blinded, no-treatment controlled, parallel group, multi-center US study to evaluate the safety and effectiveness of Restylane-L® for correction of Infraorbital Hollows.
What is the current status of trial NCT04154930?
This trial is currently completed. It is a NA study. The enrollment target is 333 participants. The study started on 2019-11-11. Estimated completion is 2022-04-06.
What interventions are being tested in trial NCT04154930?
The interventions under investigation include: Restylane-L® (DEVICE).
Who is sponsoring clinical trial NCT04154930?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04154930's enrollment target sits among peer trials
333 306th of 2000 higher than 1,695 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07395687 · 333 participants · Phase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI